Cargando…

Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease

Advancing age and disease duration both contribute to cortical thinning in Parkinson’s disease (PD), but the pathological interactions between them are poorly described. This study aims to distinguish patterns of cortical decline determined by advancing age and disease duration in PD. A convenience...

Descripción completa

Detalles Bibliográficos
Autores principales: Claassen, Daniel O., Dobolyi, David G., Isaacs, David A., Roman, Olivia C., Herb, Joshua, Wylie, Scott A., Neimat, Joseph S., Donahue, Manus J., Hedera, Peter, Zald, David H., Landman, Bennett A., Bowman, Aaron B., Dawant, Benoit M., Rane, Swati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898918/
https://www.ncbi.nlm.nih.gov/pubmed/27330836
http://dx.doi.org/10.14336/AD.2015.1110
_version_ 1782436414349115392
author Claassen, Daniel O.
Dobolyi, David G.
Isaacs, David A.
Roman, Olivia C.
Herb, Joshua
Wylie, Scott A.
Neimat, Joseph S.
Donahue, Manus J.
Hedera, Peter
Zald, David H.
Landman, Bennett A.
Bowman, Aaron B.
Dawant, Benoit M.
Rane, Swati
author_facet Claassen, Daniel O.
Dobolyi, David G.
Isaacs, David A.
Roman, Olivia C.
Herb, Joshua
Wylie, Scott A.
Neimat, Joseph S.
Donahue, Manus J.
Hedera, Peter
Zald, David H.
Landman, Bennett A.
Bowman, Aaron B.
Dawant, Benoit M.
Rane, Swati
author_sort Claassen, Daniel O.
collection PubMed
description Advancing age and disease duration both contribute to cortical thinning in Parkinson’s disease (PD), but the pathological interactions between them are poorly described. This study aims to distinguish patterns of cortical decline determined by advancing age and disease duration in PD. A convenience cohort of 177 consecutive PD patients, identified at the Vanderbilt University Movement Disorders Clinic as part of a clinical evaluation for Deep Brain Stimulation (age: M= 62.0, SD 9.3), completed a standardized clinical assessment, along with structural brain Magnetic Resonance Imaging scan. Age and gender matched controls (n=53) were obtained from the Alzheimer Disease Neuroimaging Initiative and Progressive Parkinson’s Marker Initiative (age: M= 63.4, SD 12.2). Estimated changes in cortical thickness were modeled with advancing age, disease duration, and their interaction. The best-fitting model, linear or curvilinear (2(nd), or 3(rd) order natural spline), was defined using the minimum Akaike Information Criterion, and illustrated on a 3-dimensional brain. Three curvilinear patterns of cortical thinning were identified: early decline, late decline, and early-stable-late. In contrast to healthy controls, the best-fit model for age related changes in PD is curvilinear (early decline), particularly in frontal and precuneus regions. With advancing disease duration, a curvilinear model depicts accelerating decline in the occipital cortex. A significant interaction between advancing age and disease duration is evident in frontal, motor, and posterior parietal areas. Study results support the hypothesis that advancing age and disease duration differentially affect regional cortical thickness and display regional dependent linear and curvilinear patterns of thinning.
format Online
Article
Text
id pubmed-4898918
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher JKL International LLC
record_format MEDLINE/PubMed
spelling pubmed-48989182016-06-21 Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease Claassen, Daniel O. Dobolyi, David G. Isaacs, David A. Roman, Olivia C. Herb, Joshua Wylie, Scott A. Neimat, Joseph S. Donahue, Manus J. Hedera, Peter Zald, David H. Landman, Bennett A. Bowman, Aaron B. Dawant, Benoit M. Rane, Swati Aging Dis Original Article Advancing age and disease duration both contribute to cortical thinning in Parkinson’s disease (PD), but the pathological interactions between them are poorly described. This study aims to distinguish patterns of cortical decline determined by advancing age and disease duration in PD. A convenience cohort of 177 consecutive PD patients, identified at the Vanderbilt University Movement Disorders Clinic as part of a clinical evaluation for Deep Brain Stimulation (age: M= 62.0, SD 9.3), completed a standardized clinical assessment, along with structural brain Magnetic Resonance Imaging scan. Age and gender matched controls (n=53) were obtained from the Alzheimer Disease Neuroimaging Initiative and Progressive Parkinson’s Marker Initiative (age: M= 63.4, SD 12.2). Estimated changes in cortical thickness were modeled with advancing age, disease duration, and their interaction. The best-fitting model, linear or curvilinear (2(nd), or 3(rd) order natural spline), was defined using the minimum Akaike Information Criterion, and illustrated on a 3-dimensional brain. Three curvilinear patterns of cortical thinning were identified: early decline, late decline, and early-stable-late. In contrast to healthy controls, the best-fit model for age related changes in PD is curvilinear (early decline), particularly in frontal and precuneus regions. With advancing disease duration, a curvilinear model depicts accelerating decline in the occipital cortex. A significant interaction between advancing age and disease duration is evident in frontal, motor, and posterior parietal areas. Study results support the hypothesis that advancing age and disease duration differentially affect regional cortical thickness and display regional dependent linear and curvilinear patterns of thinning. JKL International LLC 2016-05-27 /pmc/articles/PMC4898918/ /pubmed/27330836 http://dx.doi.org/10.14336/AD.2015.1110 Text en Copyright: © 2016 Claassen DO, et al. http://creativecommons.org/licenses/by/2.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Original Article
Claassen, Daniel O.
Dobolyi, David G.
Isaacs, David A.
Roman, Olivia C.
Herb, Joshua
Wylie, Scott A.
Neimat, Joseph S.
Donahue, Manus J.
Hedera, Peter
Zald, David H.
Landman, Bennett A.
Bowman, Aaron B.
Dawant, Benoit M.
Rane, Swati
Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease
title Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease
title_full Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease
title_fullStr Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease
title_full_unstemmed Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease
title_short Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease
title_sort linear and curvilinear trajectories of cortical loss with advancing age and disease duration in parkinson’s disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898918/
https://www.ncbi.nlm.nih.gov/pubmed/27330836
http://dx.doi.org/10.14336/AD.2015.1110
work_keys_str_mv AT claassendanielo linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease
AT dobolyidavidg linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease
AT isaacsdavida linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease
AT romanoliviac linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease
AT herbjoshua linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease
AT wyliescotta linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease
AT neimatjosephs linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease
AT donahuemanusj linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease
AT hederapeter linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease
AT zalddavidh linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease
AT landmanbennetta linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease
AT bowmanaaronb linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease
AT dawantbenoitm linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease
AT raneswati linearandcurvilineartrajectoriesofcorticallosswithadvancingageanddiseasedurationinparkinsonsdisease